Retraction: QbD-based rivastigmine tartrate-loaded solid lipid nanoparticles for enhanced intranasal delivery to the brain for Alzheimer's therapeutics

Bibliographic Details
Main Author: Frontiers Editorial Office
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-03-01
Series:Frontiers in Aging Neuroscience
Online Access:https://www.frontiersin.org/articles/10.3389/fnagi.2024.1399271/full
_version_ 1797236994781216768
author Frontiers Editorial Office
author_facet Frontiers Editorial Office
author_sort Frontiers Editorial Office
collection DOAJ
first_indexed 2024-04-24T17:12:42Z
format Article
id doaj.art-5b190165d9a243ed8a9ff408dd7602d3
institution Directory Open Access Journal
issn 1663-4365
language English
last_indexed 2024-04-24T17:12:42Z
publishDate 2024-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Aging Neuroscience
spelling doaj.art-5b190165d9a243ed8a9ff408dd7602d32024-03-28T08:21:59ZengFrontiers Media S.A.Frontiers in Aging Neuroscience1663-43652024-03-011610.3389/fnagi.2024.13992711399271Retraction: QbD-based rivastigmine tartrate-loaded solid lipid nanoparticles for enhanced intranasal delivery to the brain for Alzheimer's therapeuticsFrontiers Editorial Officehttps://www.frontiersin.org/articles/10.3389/fnagi.2024.1399271/full
spellingShingle Frontiers Editorial Office
Retraction: QbD-based rivastigmine tartrate-loaded solid lipid nanoparticles for enhanced intranasal delivery to the brain for Alzheimer's therapeutics
Frontiers in Aging Neuroscience
title Retraction: QbD-based rivastigmine tartrate-loaded solid lipid nanoparticles for enhanced intranasal delivery to the brain for Alzheimer's therapeutics
title_full Retraction: QbD-based rivastigmine tartrate-loaded solid lipid nanoparticles for enhanced intranasal delivery to the brain for Alzheimer's therapeutics
title_fullStr Retraction: QbD-based rivastigmine tartrate-loaded solid lipid nanoparticles for enhanced intranasal delivery to the brain for Alzheimer's therapeutics
title_full_unstemmed Retraction: QbD-based rivastigmine tartrate-loaded solid lipid nanoparticles for enhanced intranasal delivery to the brain for Alzheimer's therapeutics
title_short Retraction: QbD-based rivastigmine tartrate-loaded solid lipid nanoparticles for enhanced intranasal delivery to the brain for Alzheimer's therapeutics
title_sort retraction qbd based rivastigmine tartrate loaded solid lipid nanoparticles for enhanced intranasal delivery to the brain for alzheimer s therapeutics
url https://www.frontiersin.org/articles/10.3389/fnagi.2024.1399271/full
work_keys_str_mv AT frontierseditorialoffice retractionqbdbasedrivastigminetartrateloadedsolidlipidnanoparticlesforenhancedintranasaldeliverytothebrainforalzheimerstherapeutics